Trop2: From development to disease

Developmental Dynamics

Volumn 244, Issue 2, 2015, Pages 99-109

  Mcdougall, Annie R A ^a   Tolcos, Mary ^a   Hooper, Stuart B ^a   Cole, Timothy J ^a   Wallace, Megan J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cancer; Cell migration; Cell proliferation; EpCAM; Lung development; Tacstd2

Indexed keywords

BETA1 INTEGRIN; CELL SURFACE MARKER; CLAUDIN; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPITHELIAL CELL ADHESION MOLECULE; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TROP2 PROTEIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CONNEXIN 32; GAP JUNCTION PROTEIN; TACSTD2 PROTEIN, HUMAN; TROP2 PROTEIN, MOUSE; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BASEMENT MEMBRANE; CALCIUM SIGNALING; CANCER MORTALITY; CANCER RISK; CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CORNEA DYSTROPHY; DEVELOPMENTAL DISORDER; EMBRYO DEVELOPMENT; EXPERIMENTAL MODEL; FETUS DEVELOPMENT; GASTROINTESTINAL TRACT; GENE; GENE EXPRESSION; HEALTH; HUMAN; KIDNEY DEVELOPMENT; LUNG DEVELOPMENT; METASTASIS; MUTATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STEM CELL; TACSTD GENE; TIGHT JUNCTION; TROP2 GENE; TUMOR GROWTH; ANIMAL; CELL MOTION; CONGENITAL CORNEA DYSTROPHY; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; CONNEXINS; CORNEAL DYSTROPHIES, HEREDITARY; HUMANS; MICE; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; SIGNAL TRANSDUCTION;

EID: 84930416884     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24242     Document Type: Article

References (100)

1. Alberti S. 1999. HIKE, a candidate protein binding site for PH domains, is a major regulatory region of Gbeta proteins. Proteins 35:360-363.
2. Alcorn DG, Adamson TM, Maloney JE, Robinson PM. 1981. A morphologic and morphometric analysis of fetal lung development in the sheep. Anat Rec 201:655-667.
3. Armstrong A, Eck SL. 2003. EpCAM: A new therapeutic target for an old cancer antigen. Cancer Biol Ther 2:320-326.
4. Balzar M, Bakker HA, Briaire-de-Bruijn IH, Fleuren GJ, Warnaar SO, Litvinov SV. 1998. Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol Cell Biol 18:4833-4843.
5. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. 1999. The biology of the 17-1A antigen (Ep-CAM). J Mol Med (Berl) 77:699-712.
6. Basu A, Goldenberg DM, Stein R. 1995. The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303. Int J Cancer 62:472-479.
7. Berridge MJ. 1995. Calcium signalling and cell proliferation. Bioessays 17:491-500.
8. Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD. 2010. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. European journal of cancer 46:944-953.
9. Bignotti E, Ravaggi A, Romani C, Falchetti M, Lonardi S, Facchetti F, Pecorelli S, Varughese J, Cocco E, Bellone S, Schwartz PE, Rutherford TJ, Santin AD. 2011. Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody. Int J Gynecol Cancer 21:1613-1621.
10. Buch S, Jones C, Sweezey N, Tanswell K, Post M. 1991. Platelet-derived growth factor and growth-related genes in rat lung. I. Developmental expression. Am J Respir Cell Mol Biol 5:371-376.
11. Burri PH. 1974. The postnatal growth of the rat lung. 3. Morphology. Anat Rec 180:77-98.
12. Cardillo TM, Govindan SV, Sharkey RM, Trisal P, Goldenberg DM. 2011. Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys. Clin Cancer Res 17:3157-3169.
13. Chen R, Lu M, Wang J, Zhang D, Lin H, Zhu H, Zhang W, Xiong L, Ma J, Mao Y, Zhu J, Xu J. 2013. Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type. Virchows Arch 463:713-719.
14. Chin D, Means AR. 2000. Calmodulin: a prototypical calcium sensor. Trends Cell Biol 10:322-328.
15. Ciccarelli FD, Acciarito A, Alberti S. 2000. Large and diverse numbers of human diseases with HIKE mutations. Human molecular genetics 9:1001-1007.
16. Cubas R, Zhang S, Li M, Chen C, Yao Q. 2010. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 9:253.
17. Dean M. 1998. Cancer as a complex developmental disorder-nineteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res 58:5633-5636.
18. Dittmer J, Rody A. 2013. Cancer stem cells in breast cancer. Histol Histopathol 28:827-838.
19. El Sewedy T, Fornaro M, Alberti S. 1998. Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2. Int J Cancer 75:324-330.
20. Fields AL, Keller A, Schwartzberg L, Bernard S, Kardinal C, Cohen A, Schulz J, Eisenberg P, Forster J, Wissel P. 2009. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol 27:1941-1947.
21. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, Gastl G, Spizzo G. 2008a. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99:1290-1295.
22. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K. 2008b. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Modern Pathol 21:186-191.
23. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, Capri MG, Alberti S. 1995. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 62:610-618.
24. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D. 2009. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 80:1136-1145.
25. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON. 2010. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70:491-501.
26. Ghysen A, Dambly-Chaudiere C. 2004. Development of the zebrafish lateral line. Curr Opin Neurobiol 14:67-73.
27. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON. 2008. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 105:20882-20887.
28. Gonzalez B, Denzel S, Mack B, Conrad M, Gires O. 2009. EpCAM is involved in maintenance of the murine embryonic stem cell phenotype. Stem Cells 27:1782-1791.
29. Govindan SV, Stein R, Qu Z, Chen S, Andrews P, Ma H, Hansen HJ, Griffiths GL, Horak ID, Goldenberg DM. 2004. Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel. Breast Cancer Res Treat 84:173-182.
30. Guerra E, Trerotola M, Aloisi AL, Tripaldi R, Vacca G, La Sorda R, Lattanzio R, Piantelli M, Alberti S. 2012. The Trop-2 signalling network in cancer growth. Oncogene 32:222-233.
31. Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD. 2014. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J Gastroenterol 20:2098-2106.
32. Hammerschmidt M, Wedlich D. 2008. Regulated adhesion as a driving force of gastrulation movements. Development 135:3625-3641.
33. Herlyn D, Herlyn M, Ross AH, Ernst C, Atkinson B, Koprowski H. 1984. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods 73:157-167.
34. Kasper M, Behrens J, Schuh D, Muller M. 1995. Distribution of E-cadherin and Ep-CAM in the human lung during development and after injury. Histochem Cell Biol 103:281-286.
35. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J. 2009. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 4:e5662.
36. Lemberg MK. 2011. Intramembrane proteolysis in regulated protein trafficking. Traffic 12:1109-1118.
37. Lin H, Huang JF, Qiu JR, Zhang HL, Tang XJ, Li H, Wang CJ, Wang ZC, Feng ZQ, Zhu J. 2013. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer. Exp Mol Pathol 94:73-78.
38. Lin H, Zhang H, Wang J, Lu M, Zheng F, Wang C, Tang X, Xu N, Chen R, Zhang D, Zhao P, Zhu J, Mao Y, Feng Z. 2014. A novel human Fab antibody for Trop2 inhibits breast cancer growth in vitro and in vivo. Int J Cancer 134:1239-1249.
39. Lin JC, Wu YY, Wu JY, Lin TC, Wu CT, Chang YL, Jou YS, Hong TM, Yang PC. 2012. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol Med 4:472-485.
40. Lin MC, Almus-Jacobs F, Chen HH, Parry GC, Mackman N, Shyy JY, Chien S. 1997. Shear stress induction of the tissue factor gene. J Clin Invest 99:737-744.
41. Linnenbach AJ, Wojcierowski J, Wu SA, Pyrc JJ, Ross AH, Dietzschold B, Speicher D, Koprowski H. 1989. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci USA 86:27-31.
42. Linnenbach AJ, Seng BA, Wu S, Robbins S, Scollon M, Pyrc JJ, Druck T, Huebner K. 1993. Retroposition in a family of carcinoma-associated antigen genes. Mol Cell Biol 13:1507-1515.
43. Lipinski M, Parks DR, Rouse RV, Herzenberg LA. 1981. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci USA 78:5147-5150.
44. Liu D, Chang CH, Rossi EA, Cardillo TM, Goldenberg DM. 2013a. Interferon-lambda1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells. PLoS One 8:e63940.
45. Liu D, Sun J, Zhu J, Zhou H, Zhang X, Zhang Y. 2014. Expression and clinical significance of colorectal cancer stem cell marker EpCAM/CD44 in colorectal cancer. Oncol Lett 7:1544-1548.
46. Liu M, Xu J, Liu J, Kraw ME, Tanswell AK, Post M. 1995. Mechanical strain-enhanced fetal lung cell proliferation is mediated by phospholipase C and D and protein kinase C. Am J Physiol 268:L729-738.
47. Liu T, Liu Y, Bao X, Tian J, Liu Y, Yang X. 2013b. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS One 8:e75864.
48. Lu H, Ma J, Yang Y, Shi W, Luo L. 2013. EpCAM is an endoderm-specific Wnt derepressor that licenses hepatic development. Dev Cell 24:543-553.
49. Lu J, Izvolsky KI, Qian J, Cardoso WV. 2005. Identification of FGF10 targets in the embryonic lung epithelium during bud morphogenesis. J Biol Chem 280:4834-4841.
50. Lupu VD, Kaznacheyeva E, Krishna UM, Falck JR, Bezprozvanny I. 1998. Functional coupling of phosphatidylinositol 4, 5-bisphosphate to inositol 1, 4, 5-trisphosphate receptor. J Biol Chem 273:14067-14070.
51. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O. 2009. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 11:162-171.
52. Mangino G, Grazia Capri M, Barnaba V, Alberti S. 2002. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells. Int J Cancer 101:353-359.
53. McDougall AR, Hooper SB, Zahra VA, Cole TJ, Lo CY, Doran T, Wallace MJ. 2013. Trop2 regulates motility and lamellipodia formation in cultured fetal lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 305:L508-521.
54. McDougall AR, Hooper SB, Zahra VA, Sozo F, Lo CY, Cole TJ, Doran T, Wallace MJ. 2011. The oncogene Trop2 regulates fetal lung cell proliferation. Am J Physiol 301:L478-489.
55. McQualter JL, Yuen K, Williams B, Bertoncello I. 2010. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA 107:1414-1419.
56. Mihelic M, Turk D. 2007. Two decades of thyroglobulin type-1 domain research. Biol Chem388:1123-1130.
57. Mustata RC, Vasile G, Fernandez-Vallone V, Strollo S, Lefort A, Libert F, Monteyne D, Perez-Morga D, Vassart G, Garcia MI. 2013. Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium. Cell Rep 5:421-432.
58. Nagao K, Zhu J, Heneghan MB, Hanson JC, Morasso MI, Tessarollo L, Mackem S, Udey MC. 2009. Abnormal placental development and early embryonic lethality in EpCAM-null mice. PLoS One 4:e8543.
59. Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, Matsubara H, Nomura F, Takiguchi M, Hiwasa T. 2004. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 112:1029-1035.
60. Nakatsukasa M, Kawasaki S, Yamasaki K, Fukuoka H, Matsuda A, Tsujikawa M, Tanioka H, Nagata-Takaoka M, Hamuro J, Kinoshita S. 2010. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol 177:1344-1355.
61. Nardo L, Hooper SB, Harding R. 1995. Lung hypoplasia can be reversed by short-term obstruction of the trachea in fetal sheep. Pediatr Res 38:690-696.
62. Ning S, Liang N, Liu B, Chen X, Pang Q, Xin T. 2013. TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas. Neurol Sci 34:1745-1750.
63. Novinec M, Kordis D, Turk V, Lenarcic B. 2006. Diversity and evolution of the thyroglobulin type-1 domain superfamily. Mol Biol Evol 23:744-755.
64. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. 2006. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12:3057-3063.
65. Okabe M, Tsukahara Y, Tanaka M, Suzuki K, Saito S, Kamiya Y, Tsujimura T, Nakamura K, Miyajima A. 2009. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 136:1951-1960.
66. Pau Ni IB, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Aina Emran N, Hisham Abdullah N, Syed Hussain SN. 2010. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract 206:223-228.
67. Punt CJ, Nagy A, Douillard JY, Figer A, Skovsgaard T, Monson J, Barone C, Fountzilas G, Riess H, Moylan E, Jones D, Dethling J, Colman J, Coward L, MacGregor S. 2002. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet 360:671-677.
68. Raji R, Guzzo F, Carrara L, Varughese J, Cocco E, Bellone S, Betti M, Todeschini P, Gasparrini S, Ratner E, Silasi DA, Azodi M, Schwartz P, Rutherford TJ, Buza N, Pecorelli S, Santin AD. 2011. Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. J Exp Clin Cancer Res 30:106.
69. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, et al. 1994. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 343:1177-1183.
70. Ripani E, Sacchetti A, Corda D, Alberti S. 1998. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76:671-676.
71. Schnell U, Cirulli V, Giepmans BN. 2013a. EpCAM: structure and function in health and disease. Biochim Biophys Acta 1828:1989-2001.
72. Schnell U, Kuipers J, Giepmans BN. 2013b. EpCAM proteolysis: new fragments with distinct functions? Biosci Rep 33:e00030.
73. Sharkey RM, Govindan SV, Cardillo TM, Goldenberg DM. 2012. Epratuzumab-SN-38: a new antibody-drug conjugate for the therapy of hematologic malignancies. Mol Cancer Ther 11:224-234.
74. Sharkey RM, Karacay H, Govindan SV, Goldenberg DM. 2011. Combination radioimmunotherapy and chemoimmunotherapy involving different or the same targets improves therapy of human pancreatic carcinoma xenograft models. Mol Cancer Ther 10:1072-1081.
75. Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM. 1995. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer. Cancer Res 55:5857s-5863s.
76. Slanchev K, Carney TJ, Stemmler MP, Koschorz B, Amsterdam A, Schwarz H, Hammerschmidt M. 2009. The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development. PLoS Genet 5:e1000563.
77. Solimini NL, Luo J, Elledge SJ. 2007. Non-oncogene addiction and the stress phenotype of cancer cells. Cell 130:986-988.
78. Sozo F, Wallace MJ, Zahra VA, Filby CE, Hooper SB. 2006. Gene expression profiling during increased fetal lung expansion identifies genes likely to regulate development of the distal airways. Physiol Genom 24:105-113.
79. Stein R, Basu A, Chen S, Shih LB, Goldenberg DM. 1993. Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody. Int J Cancer 55:938-946.
80. Stein R, Chen S, Sharkey RM, Goldenberg DM. 1990. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting. Cancer Res 50:1330-1336.
81. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON. 2012. Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via beta-catenin signaling. Genes Dev 26:2271-2285.
82. Szala S, Froehlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H, Linnenbach AJ. 1990. Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87:3542-3546.
83. Takaoka M, Nakamura T, Ban Y, Kinoshita S. 2007. Phenotypic investigation of cell junction-related proteins in gelatinous drop-like corneal dystrophy. Invest Ophthalmol Vis Sci 48:1095-1101.
84. Trerotola M, Guerra E, Alberti S. 2010a. Letter to the editor: efficacy and safety of anti-Trop antibodies, R. Cubas, M. Li, C. Chen and Q. Yao. Biochim Biophys Acta 1796 (2009) 309-311. Biochim Biophys Acta 1805:119-120; author reply 121-112.
85. Trerotola M, Rathore S, Goel HL, Li J, Alberti S, Piantelli M, Adams D, Jiang Z, Languino LR. 2010b. CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2:135-144.
86. Trerotola M, Li J, Alberti S, Languino LR. 2012. Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the beta1 integrin-RACK1 axis. J Cell Physiol 227:3670-3677.
87. Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, Bonasera V, Lattanzio R, Lange R, Weidle UH, Piantelli M, Alberti S. 2013a. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 32:222-233.
88. Trerotola M, Jernigan DL, Liu Q, Siddiqui J, Fatatis A, Languino LR. 2013b. Trop-2 promotes prostate cancer metastasis by modulating beta(1) integrin functions. Cancer Res 73:3155-3167.
89. Tsujikawa M, Kurahashi H, Tanaka T, Nishida K, Shimomura Y, Tano Y, Nakamura Y. 1999. Identification of the gene responsible for gelatinous drop-like corneal dystrophy. Nat Genet 21:420-423.
90. Tsukahara Y, Tanaka M, Miyajima A. 2011. TROP2 expressed in the trunk of the ureteric duct regulates branching morphogenesis during kidney development. PLoS One 6:e28607.
91. Varughese J, Cocco E, Bellone S, Bellone M, Todeschini P, Carrara L, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. 2011a. High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Gynecol Oncol 122:171-177.
92. Varughese J, Cocco E, Bellone S, de Leon M, Bellone M, Todeschini P, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. 2011b. Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody. Cancer 117:3163-3172.
93. Varughese J, Cocco E, Bellone S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S, Santin AD. 2011c. Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Am J Obstet Gynecol 205:567 e561-567.
94. Villablanca EJ, Renucci A, Sapede D, Lec V, Soubiran F, Sandoval PC, Dambly-Chaudiere C, Ghysen A, Allende ML. 2006. Control of cell migration in the zebrafish lateral line: implication of the gene "tumour-associated calcium signal transducer, "tacstd. Dev Dyn 235:1578-1588.
95. Wallace MJ, Hooper SB, McDougall ARA. 2014. Physical, endocrien and growth factors in lung development. In: Harding R, Pinkerton K, editors. The lung: development, ageing and the environment. London: Elsevier Academic Press.
96. Wang J, Day R, Dong Y, Weintraub SJ, Michel L. 2008. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Therapeut 7:280-285.
97. Wang J, Zhang K, Grabowska D, Li A, Dong Y, Day R, Humphrey P, Lewis J, Kladney RD, Arbeit JM, Weber JD, Chung CH, Michel LS. 2011. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma. Mol Cancer Res 9:1686-1695.
98. Wu H, Xu H, Zhang S, Wang X, Zhu H, Zhang H, Zhu J, Huang J. 2013. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma. Head Neck 35:1373-1378.
99. Yang J, Zhu Z, Wang H, Li F, Du X, Ma RZ. 2013. Trop2 regulates the proliferation and differentiation of murine compact-bone derived MSCs. Int J Oncol 43:859-867.
100. Zhang K, Jones L, Lim S, Maher CA, Adkins D, Lewis J, Kimple RJ, Fertig EJ, Chung CH, Herrlich A, Ellis MJ, Van Tine BA, Michel LS. 2014. Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC. Oncotarget 5:9281-9294.